baber/WOPTO huggingface dataset:
Patent ES-2558862-T3 (ES)
Title: Cabeza de lectura de longitud de onda múltiple para utilización en la determinación de analitos en fluidos corporales
Inventor: REYNOLDS JEFFREY S
IPC: G01N21/84
Filed: 2004-02-10
Granted: 2016-02-09
Abstract: Una cabeza (10) de lectura para su uso en la determinación de la concentración de un analito en una muestra, comprendiendo la cabeza (10) de lectura: un área (30) de lectura para recibir la muestra; una pluralidad de elementos (12) de emisión de luz para emitir luz a una pluralidad de longitudes de onda; una guía (16) de luz que tiene un extremo de entrada y un extremo (18) de salida, estando el extremo de entrada directamente acoplado ópticamente a la pluralidad de elementos (12) de emisión de luz para recibir la luz emitida por la pluralidad de elementos (12) de emisión de luz, teniendo el extremo de entrada un centro que está defasado del centro de al menos uno de la pluralidad de elementos (12) de emisión de luz, guiando la guía (16) de luz una porción sustancial de la luz recibida al extremo (18) de salida; una lente (22) para recibir luz del extremo (18) de salida de la guía (16) de luz y para iluminar la muestra con un rayo (26) colimado de luz; y un detector (34) adaptado para detectar luz (36) transmitida de la muestra como respuesta a la iluminación de la muestra, caracterizada porque la guía de luz tiene una sección transversal cuadrada.
Patent ES-2266932-T3 (ES)
Inventor: STORCK HOLGER
IPC: A47B88/493
Filed: 2004-02-14
Granted: 2007-03-01
Abstract: The outer channel section (1) houses an intermediate channel section (2) having a series of smaller diameter rollers ((9,10), running on return sections (7,8), and two larger diameter rollers (35) running on the third channel section (3) and the upper section (4) of the first rail.
Patent ES-2285310-T3 (ES)
Inventor: SCHLIESSER GERHARD
IPC: A22C11/10
Filed: 2004-06-14
Granted: 2007-11-16
Abstract: The sausage skin filling machine (1) has a filling pipe (2) for injecting sausage meat. A clip module (4) is connected to a sausage skin brake (3). The sausages are moved by two endless conveyer belts (5a,5b) facing each other. There is a band separation arrangement (6) and an adjustable support arrangement (7). Automatic manufacture of the sausages involves feeding portions of the sausage meat into sections of sausage skins with controlled timing. The brake can control the movement of the sausage skin.
Patent ES-2312917-T3 (ES)
Title: Composiciones farmaceuticas que comprenden antagonistas de taquiquininas y un inhibidor de la recaptacion de serotonina.
Inventor: MELOTTO SERGIO
IPC: C07D401/06
Filed: 2000-10-05
Granted: 2009-03-01
Abstract: Una composición que comprende un compuesto de fórmula (I) (Ver fórmula) en el que R representa un átomo de halógeno o un grupo alquilo C1 - 4; R1 representa hidrógeno o un grupo alquilo C1 - 4; R2 representa hidrógeno, un grupo alquilo C1 - 4, o un grupo alquenilo C2 - 6 o cicloalquilo C3 - 7; o R1 y R2 junto con el átomo de nitrógeno y carbono al que están unidos respectivamente representan un grupo heterocíclico de 5 a 6 miembros; R3 representa un grupo trifluorometilo, un alquilo C1 - 4, un alcoxi C1 - 4, un trifluorometoxi o un halógeno; R4 representa hidrógeno, un grupo (CH2)qR7 o (CH2)rCO(CH2)pR7; R5 representa hidrógeno o un grupo alquilo C1 - 4 o un COR6; R7 representa hidrógeno, hidroxi o NR8R9 en el que R8 y R9 representan independientemente hidrógeno o alquilo C1 - 4 opcionalmente sustituido por hidroxi o por amino; R10 representa hidrógeno, un grupo alquilo C1 - 4 o R10 junto con R2 representa un grupo cicloalquilo C3 - 7; m es cero o un número entero de 1 a 3; n es cero o un número entero de 1 de 3; tanto p como r son independientemente cero o un número entero de 1 a 4; q es un número entero de 1 a 4; a condición de que, cuando R1 y R2 junto con el átomo de nitrógeno y carbono al que están unidos respectivamente representan un grupo heterocíclico de 5 a 6 miembros, i) m sea 1 ó 2; ii) cuando m es 1, R no sea flúor y iii) cuando m es 2, los dos sustituyentes R no sean ninguno flúor, o sus sales o solvatos farmacéuticamente aceptables y un inhibidor selectivo de la recaptación de serotonina.
Patent ES-2314345-T3 (ES)
Title: Composiciones de producto personal que comprenden una premezcla de un agente benefico estructurado.
Inventor: ZHANG XIAODONG
IPC: C11D7/22
Filed: 2004-05-21
Granted: 2009-03-16
Abstract: Una composición de producto para el cuidado personal que comprende: (1) del 1% al 99% en peso de un material tensioactivo seleccionado entre tensioactivos aniónicos, no iónicos, anfóteros, catiónicos y mezclas de los mismos; y (2) del 0,1% al 90%, de una composición de agente beneficioso estructurado, que comprende: (a) del 50 al 99,9% en peso de una composición de agente beneficioso estructurado de uno o mas o más agentes beneficiosos o mezclas de los mismos; y (b) del 50% al 0,1% del material estructurante del agente beneficioso estructurado, seleccionado entre estructurantes cristalinos seleccionados entre ceras cristalinas naturales o sintéticas; (3) un modificador o modificadores ópticos seleccionados entre partículas insolubles en agua, en la que el cristal en el material estructurante tienen una relación de aspecto definida por A/B > 1, entendiéndose que la longitud A es la más larga de las dos dimensiones cuando se consideran la longitud y la anchura, B; en la que el agente beneficioso estructurado se genera independientemente y se combina independientemente con una composición portadora, que contiene tensioactivos, en la que el agente beneficioso estructurado se usará para administrar el agente beneficioso a un sustrato, y se proporciona un beneficio aumentado de partículas insolubles en agua de, al menos un 5%, respecto al efecto proporcionado por las mismas partículas insolubles en agua en ausencia de un agente beneficioso estructurado en la composición final.
Patent ES-2268644-T3 (ES)
Inventor: LUTZ CHRISTIAN
IPC: A61B17/68
Filed: 2004-03-17
Granted: 2007-03-16
Abstract: An implantable orthopedic device having a load-bearing element, such as a bone plate, with at least one opening for a fixation element and one insert which can be inserted in an inclined opening in a receptacle in the bore. This insert has an external form that is at least partially complementary to the internal form of the receptacle and a central through-bore for receiving the body of the fixation element such as a bone screw. The insert also provides a locking system for holding the insert in the receptacle, in which the insert exhibits at least one locking mechanism with which conformal locking with the load-bearing element may be achieved.
Patent ES-2328245-T3 (ES)
Inventor: LUXEM FRANZ J
IPC: C11C3/10
Filed: 2004-07-07
Granted: 2009-11-11
Abstract: A method for making alkyl esters (e.g., methyl ester), such as biodiesel, from an oil source is described. The method involves converting the free fatty acids of the oil source into a mixture of mono-, di-, and tri-glycerides and subsequently transesterifying the newly formed glycerides as well as the originally present glycerides into fatty acid alkyl esters.
Patent ES-2238022-T3 (ES)
Inventor: RUKHMAN IGOR
IPC: A61K31/4184
Filed: 2004-03-17
Granted: 2008-11-01
Abstract: Provided are crystalline and amorphous form of valsartan, and processes for their preparation.
Patent ES-2302014-T3 (ES)
Inventor: PETKOV MIHAIL DANEV
IPC: E04B1/18
Filed: 2004-09-15
Granted: 2008-07-01
Abstract: The complex, intended for application in big cities or city centers, where space for garages, storehouses and similar facilities is to be ensured, comprises a yard ( 1 ), situated between roadways ( 2 ) and railed off by a fence ( 3 ) with entrance door ( 4 ). In the yard ( 1 ) a school building ( 5 ) is situated and a sports-, play- and common activities zone ( 6 ) is shaped. In this zone ( 6 ), there is an at least two-storeyed underground construction ( 7 ), to which an approach ( 10 ) is shaped. In the approach area ( 10 ) there is a single-storeyed over-ground part ( 11 ). The construction ( 7 ) includes walls ( 12 ), bearing intermediate pillars ( 13 ) and floor panels ( 14 ) founding on the longitudinal footings of supporting beams ( 15 ). The pillars ( 13 ) have short consoles ( 16 ), where the beams ( 15 ) are mounted and they are restrained in monolithic footings ( 20 ), with their bottom ribbed ends ( 21 ) placed in preliminary prepared cups ( 22 ) encompassing this ribbed ends ( 21 ). The cups ( 22 ) have an internal ribbed surface ( 23 ) and partial outer ribbing ( 24 ).
Patent ES-2291940-T3 (ES)
Inventor: MCCORMICK PATRICK
IPC: E02F3/36
Filed: 2004-09-20
Granted: 2008-03-01
Abstract: Excavator tool quick attachment device (1) is used to attach a tool to a dipper arm (2) of an excavator. Body member (52) has two receivers (12,14) for tool pins (11,15). Receiver (12) has a movable latch (3) powered by an hydraulic ram (20) for securing and releasing pin (11) and receiver (14) has a movable spring loaded lock (22) for securing and releasing pin (15). A control assembly (21) is connected between latch (3) and lock (22) but only operates to release lock (22) when the device (1) is inverted relative to a normal working position and the hydraulic ram (20) is activated.
Patent ES-2389438-T3 (ES)
Title: Control de la oxigenación
Inventor: FLECKNOE-BROWN ANTHONY EARL
IPC: C12H1/12
Filed: 2004-11-25
Granted: 2012-10-26
Abstract: Un método para controlar la tasa de transferencia de oxígeno de la atmósfera al vino, que comprendealmacenar el vino en un recipiente cerrado (4) con paredes expuestas a la atmósfera a la presión atmosférica,en donde el recipiente (4) es auto-soportante, y las paredes del recipiente comprenden un material de plástico rígidoque permite que el oxígeno penetre a través de las paredes directamente desde la atmósfera al vino en contacto conlas paredes, a una tasa de 13 mg a 65 mg de oxígeno atmosférico por metro cuadrado de la superficie de pared porcada milímetro del espesor de pared durante cada período de 24 horas a la temperatura ambiente, yen donde el vino se almacena en el recipiente durante un período que oscila entre 4 meses y 36 meses, y la tasatotal de transmisión de oxígeno al vino es menor que 55 mg/litro de vino/año.
Patent ES-2284084-T3 (ES)
Inventor: STORK MARTIN
IPC: C08L25/12
Filed: 2004-12-14
Granted: 2007-11-01
Abstract: The present invention relates to thermoplastic molding compositions comprising a mixture of (A) from 30 to 69% by weight, based on the sum of components (A), (B) and (C), of a methyl methacrylate polymer, (B) from 30 to 69% by weight, based on the sum of components (A), (B) and (C), of a copolymer obtainable by polymerizing a styrenic monomer and a vinyl cyanide, and (C) from 1 to 40% by weight, based on the sum of components (A), (B) and (C), of a graft copolymer obtainable from (C1) from 60 to 90% by weight, based on (C), of a core obtainable by polymerizing a 1,3-diene and a styrenic monomer, (C2) from 5 to 20% by weight, based on (C), of a first graft shell, and (C3) from 5 to 20% by weight, based on (C), of a second graft shell composed of an alkyl (meth)acrylate polymer, with the proviso that the ratio of (C2) to (C3) is in the range from 2:1 to 1:2.
Patent ES-2354360-T3 (ES)
Inventor: NICOLAIDES NICHOLAS
IPC: A61K38/00
Filed: 1996-08-23
Granted: 2011-03-14
Abstract: The present invention relates to the use of an antibody, which is an anti-interleukin-9 antibody or an anti-interleukin-9 receptor antibody, that blocks interleukin-9 binding to the interleukin-9 receptor, for the preparation of a medicament for the reduction of bronchial hyper-responsiveness in a patient.
Patent ES-2296066-T3 (ES)
Inventor: CORGHI REMO
IPC: G01D11/30
Filed: 2005-10-10
Granted: 2008-04-16
Abstract: A support bracket (1) for sensors adapted to be fastened to the wheel cover of a wheel mounted on a vehicle, comprising a central body from which there derives on one side a support device (3) of the sensor, and on the opposite side at least three devices (7) adapted to be engaged in the lugs which fasten the wheel cover to the vehicle; at least one of said engagement devices (7) comprises a jaw (73), placed at the end of a rod (72) sliding in a tubular body (70), adapted to be inserted on the head of a fastening screw of the wheel cover, means being foreseen to slide the rod in the tubular body so that it enlarges and tightens the jaw.
Patent ES-2279490-T3 (ES)
Inventor: GOURNAY JOSE
IPC: A61B17/70
Filed: 2005-05-19
Granted: 2007-08-16
Abstract: Device for connecting the rod (13) of a spinal osteosynthesis device to a vertebra (14) or to two vertebrae, of the type comprising a first hook (1) provided with a threaded protrusion (3) for fitting a connector (11) in which said rod is inserted, a second hook (5), a rod (6) of small diameter connecting the two hooks (1, 5), and means for immobilizing the ends of said rod (6) of small diameter on the heads (2, 8) of the hooks (1, 5), characterized in that the end of the rod (6) of small diameter in contact with said first hook comprises an oblong aperture (10), and in that the means for immobilizing this end on the head (2) of the first hook (1) are formed by a nut (15, 16) intended to cooperate with the connector (11). <??>Spinal osteosynthesis device comprising the above connection device. <IMAGE>
Patent ES-2391022-T3 (ES)
Inventor: MORALES ARNAEZ AGUSTIN
IPC: B29C45/14
Filed: 2005-06-14
Granted: 2012-11-20
Abstract: A connection and stress transmission element for automotive vehicle mechanisms, the apparatus and the process for manufacturing the joining element by overinjection. The joining element has a central portion (1) and a first end portion (2). The central portion (1) is of a material providing mechanical resistance and is bar-shaped, having a first end and a second end. The first end portion (2) is of plastic material overinjected on the first end such that the central portion (1) and the first end portion (2) form a single-piece joining element. The apparatus has: containing devices (100) to define a cavity (110) between the surface to be overinjected and the containing devices (100); input devices (200) and output deices (300) in the containing devices (100) so that the overinjection product is introduced in and extracted from the cavity (110).
Patent ES-2354997-T3 (ES)
Inventor: BOHLEN HERIBERT
IPC: C12Q1/02
Filed: 2005-05-11
Granted: 2011-03-21
Abstract: Provided are assay systems for determining the therapeutic or toxic effect of a putative drug based on assaying its activity in cells which have been differentiated in vitro from stem cells, and induced to display a phenotype that resembles a disease to be treated.
Patent ES-2552219-T3 (ES)
Title: Proceso para preparar bisulfato de atazanavir y nuevas formas
Inventor: KIM SOOJIN
IPC: C07D213/56
Filed: 2005-05-03
Granted: 2015-11-26
Abstract: Un proceso para preparar bisulfato de atazanavir en la forma de cristales de Forma A, que comprende hacer reaccionar una solución de base libre de atazanavir en un disolvente orgánico, que es acetona o una mezcla de acetona y N-metilpirrolidona, con una primera porción de ácido sulfúrico concentrado en una cantidad para reaccionar con menos de aproximadamente el 15 % en peso de la base libre de atazanavir, agregar semillas de los cristales de Forma A de bisulfato de atazanavir a la mezcla de reacción, como cristales de forma de bisulfato de atazanavir, agregar ácido sulfúrico concentrado adicional en etapas múltiples a una velocidad incrementada de acuerdo con la siguiente ecuación**Fórmula** donde Vtiempo >= Volumen de ácido sulfúrico agregado durante el período de tiempo transcurrido Vtotal >= Volumen total de ácido que representa el 90 % de carga tiempo >= Tiempo transcurrido en la cristalización tiempototal >= Tiempo de cristalización total o tiempo total para cargado de ácido para efectuar la formación de cristales de bisulfato de atazanavir, y secar el bisulfato de atazanavir para formar los cristales de Forma A.
Patent ES-2358025-T3 (ES)
Inventor: INGRAHAM BRIAN
IPC: A61J1/05
Filed: 2005-07-21
Granted: 2011-05-04
Abstract: An autoclavable sterilization bag is provided having first and second composite film laminates positioned in opposing relation and sealed to one another to form a pouch. At least the first laminate comprises a heat sealable transparent thermoplastic polymer inner layer forming an inner surface of the laminate and a transparent polymer film outer layer. A transparent barrier layer is located between the inner and outer layers and formed of molecularly oriented polychlorotrifluoroethylene (PCTFE). In advantageous specific embodiments of the invention, the heat sealable transparent thermoplastic polymer inner layer is a polyolefin film, and the transparent polymer outer layer is a film selected from the group consisting of polyethylene terephthalate, nylon, polypropylene, polyethylene and cellophane.
Patent ES-2321119-T3 (ES)
Title: Cabezal de dragado para una tolva de aspiracion remolcada y proceso para dragar por medio de este cabezal de dragado.
Inventor: TACK BRUNO
IPC: E02F3/92
Filed: 2005-08-30
Granted: 2009-06-02
Abstract: Cabezal de dragado (1) para una tolva de aspiración remolcada, que comprende una visera (2), rotativa alrededor de un primer eje (6) para remover el suelo, y un tubo de aspiración (31) conectado a la visera (2) para la extracción del suelo aflojado, caracterizado por el hecho de que el cabezal de dragado (1) está provisto de una placa de presión (21) que comprende un número de cuerpos de penetración con una forma principalmente de disco (22) sobre el lado de cara al suelo de la placa de presión (21), de tal manera que su borde circunferencial (23) es capaz de transferir fuerzas hacia el suelo.
Patent ES-2379799-T3 (ES)
Inventor: BEJGER THOMAS
IPC: C08B37/00
Filed: 2005-08-12
Granted: 2012-05-03
Abstract: A reduced odor composition is composed of a functional system such as household care, personal care or pet care products and at least one cationic polygalactomannan or a derivative of cationic polygalactomannan having a cationic degree of substitution (DS) lower limit of about 0.01 and an upper limit of about 3.0 and weight average molecular weight (Mw) having a lower limit of 200,000 and an upper limit of 2,000,000 a concentration with a lower limit of 0.005 wt % and an upper limit of 10 wt %, and a trimethylamine content of less than 25 ppm, wherein the composition, at an alkaline pH, has no discernible amine odor.
Patent ES-2616179-T3 (ES)
Title: Inmunorregulación en cáncer, enfermedades inflamatorias crónicas y autoinmunitarias
Inventor: HÅKANSSON LEIF
IPC: A61P37/04
Filed: 2005-10-20
Granted: 2017-06-09
Abstract: Uso de un anticuerpo monoclonal externamente producido o fragmento del mismo, dirigido contra un factor de unión a integrinas, para la fabricación de una composición farmacéutica para mejorar el control tumoral inmunomediado espontáneo o terapéuticamente inducido, en donde dicho factor de unión a integrinas comprende estructuras presentes en fragmentos desnaturalizados o proteolíticos de proteínas normalmente producidas, y está presente en extractos tumorales o sueros de pacientes de cáncer, en donde dicho factor de unión a integrinas está implicado en la disregulación de funciones inmunitarias, en donde el anticuerpo monoclonal se une a un epítopo que comprende un sitio de unión a integrinas ß2 de una dHSA, y en donde el anticuerpo monoclonal previene, inhibe y/o aumenta la actividad del factor de unión a integrinas.
Patent ES-2439229-T3 (ES)
Title: Relevancia de niveles logrados de marcadores de inflamación sistémica tras el tratamiento
Inventor: RIDKER PAUL M
IPC: G01N33/68
Filed: 2005-10-06
Granted: 2014-01-22
Abstract: Un método in vitro para diagnosticar si un sujeto humano, bajo terapia con una estatina para reducir el riesgo deun suceso cardiovascular futuro, se beneficiaría de una terapia continuada con la estatina, o se beneficiaría de uncambio en la terapia con la estatina, que comprende: (i) obtener un nivel de proteína reactiva C (CRP) en el sujeto humano; y (ii) obtener un nivel de colesterol de lipoproteínas de baja densidad (LDLC) en el sujeto humano; en el que un nivel de CRP obtenido en (i) por debajo de 2 mg/l indica que el sujeto se beneficiaría de la terapiacontinuada con la estatina, y un nivel de CRP obtenido en (i) por encima de 2 mg/l indica que el sujeto sebeneficiaría de un cambio en la terapia con la estatina, cuando el nivel de LDLC obtenido en (ii) está por debajo de70 mg/dl.
Patent ES-2339137-T3 (ES)
Inventor: CROS FRANCOIS
IPC: G06T17/10
Filed: 2005-09-05
Granted: 2010-05-17
Abstract: The device comprises means for taking a height measurement (H) and a plurality of circumference measurements (b, c, g) on the limb of the patient at different predetermined z-positions (zb, zc, zg). A first data file includes the coordinates (X0, Y0, Z0) of a first mesh of points (24) representative of the morphological characteristics of a reference limb, these points being distributed over the surface of the reference limb along a succession of outlines (26) defined at different successive Z-positions. Morphology generator means recalculate the coordinates of the first mesh of points as a function of the height measurement (H) and of the circumference measurements (b, c, g) in such a manner as to produce a second data file comprising the coordinates (x, y, z) of a second mesh of points (52) representative of morphological characteristics of the patient's limb.
Patent ES-2472271-T3 (ES)
Title: Procedimiento para la producción de N,N-duimetilacetamida (DMAC)
Inventor: GRAFMANS HORST
IPC: C07C231/02
Filed: 2005-12-03
Granted: 2014-06-30
Abstract: Procedimiento para la producción de N,N-dimetilacetamida (DMAC) mediante reacción en continuo de acetato de metilo (MeOAc) con dimetilamina (DMA) en presencia de un catalizador básico, caracterizado porque el MeOAc se usa como solución metanólica, que se genera en la producción de poliTHF mediante transesterificación de diacetato de poliTHF con metanol como producto secundario
Patent ES-2332103-T3 (ES)
Inventor: JIANG TAO
IPC: A61F5/58
Filed: 2005-11-21
Granted: 2010-01-26
Abstract: The present invention is directed to a wearable stutter reducing device incorporating novel methods that make extensive use of digital signal processing (DSP) technology. The wearable stutter reducing device of the present invention has an audio signal receiver for receiving speech signals corresponding to a wearer's voice. An input conversion means for converting the speech signals and noise mixed with the speech signals into frequency domain components is in communication with the audio signal receiver. A channelization means in communication with the conversion means separates the frequency domain components into a plurality of channels. An identifying means in communication with the plurality of channels identifies which channels of the plurality of channels contain substantially more speech corresponding frequency domain components than noise corresponding frequency components. An amplification means for amplifying signals identified as speech is in communication with the identifying means. The present invention also includes a frequency altering means for altering the frequency of a predetermined number of channels and an output conversion means in communication with the amplification means for converting the frequency components into time domain signals containing amplified speech.